| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1345576 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of DUSP5 mRNA | CTD | PMID:22079256 |
| 1,2,4-trimethylbenzene | increases expression | EXP | | 6480464 | pseudocumene results in increased expression of DUSP5 protein | CTD | PMID:17337753 |
| 1,3-dinitrobenzene | increases expression | EXP | | 6480464 | 3-dinitrobenzene results in increased expression of DUSP5 mRNA | CTD | PMID:21983209 |
| 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of DUSP5 mRNA | CTD | PMID:20170705 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:1345576 | 6480464 | Ethinyl Estradiol results in increased expression of DUSP5 mRNA | CTD | PMID:18936297 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:1345576 | 6480464 | Ethinyl Estradiol affects the expression of DUSP5 mRNA | CTD | PMID:20170705 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1345576 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of DUSP5 mRNA | CTD | PMID:19619570 |
| 17beta-estradiol | increases expression | ISO | RGD:1345576 | 6480464 | Estradiol results in increased expression of DUSP5 mRNA | CTD | PMID:19153601 more ... |
| 17beta-estradiol | increases expression | ISO | RGD:1345576 | 6480464 | Estradiol results in increased expression of DUSP5 mRNA | CTD | PMID:19619570 more ... |
| 17beta-estradiol | increases expression | ISO | RGD:1345576 | 6480464 | Estradiol results in increased expression of DUSP5 mRNA | CTD | PMID:19619570 more ... |
| 17beta-estradiol | increases expression | ISO | RGD:1345576 | 6480464 | Estradiol results in increased expression of DUSP5 mRNA | CTD | PMID:19153601 more ... |
| 17beta-estradiol | increases expression | ISO | RGD:1345576 | 6480464 | Estradiol results in increased expression of DUSP5 mRNA | CTD | PMID:19153601 more ... |
| 17beta-estradiol | increases expression | ISO | RGD:1345576 | 6480464 | Estradiol results in increased expression of DUSP5 mRNA | CTD | PMID:20106945 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1345576 | 6480464 | alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in decreased expression of DUSP5 mRNA]; more ... | CTD | PMID:19578757 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1345576 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of DUSP5 mRNA | CTD | PMID:12377990 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1345576 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of DUSP5 mRNA | CTD | PMID:19619570 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1345576 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of DUSP5 mRNA | CTD | PMID:12377990 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1345576 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of DUSP5 mRNA | CTD | PMID:12377990 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1622924 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of DUSP5 mRNA | CTD | PMID:19933214 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1345576 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of DUSP5 mRNA | CTD | PMID:20106945 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1345576 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of DUSP5 mRNA | CTD | PMID:19619570 |
| 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of DUSP5 mRNA | CTD | PMID:21346803 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | EXP | | 6480464 | Glucosamine inhibits the reaction [IL1B results in increased expression of DUSP5 mRNA] | CTD | PMID:17109745 |
| 2-amino-2-deoxy-D-glucopyranose | increases expression | EXP | | 6480464 | Glucosamine results in increased expression of DUSP5 mRNA | CTD | PMID:17109745 |
| 5-fluorouracil | multiple interactions | ISO | RGD:1345576 | 6480464 | TP53 protein affects the reaction [Fluorouracil results in increased expression of DUSP5 mRNA] | CTD | PMID:15016801 |
| acetylsalicylic acid | affects expression | EXP | | 6480464 | Aspirin affects the expression of DUSP5 mRNA | CTD | PMID:12800193 |
| aflatoxin B1 | affects expression | ISO | RGD:1345576 | 6480464 | Aflatoxin B1 affects the expression of DUSP5 protein | CTD | PMID:20106945 |
| aflatoxin B1 | increases expression | ISO | RGD:1345576 | 6480464 | Aflatoxin B1 results in increased expression of DUSP5 mRNA | CTD | PMID:21632981 PMID:21641981 |
| aflatoxin B1 | increases expression | ISO | RGD:1345576 | 6480464 | Aflatoxin B1 results in increased expression of DUSP5 mRNA | CTD | PMID:21641981 |
| aldehydo-D-glucosamine | multiple interactions | EXP | | 6480464 | Glucosamine inhibits the reaction [IL1B results in increased expression of DUSP5 mRNA] | CTD | PMID:17109745 |
| aldehydo-D-glucosamine | increases expression | EXP | | 6480464 | Glucosamine results in increased expression of DUSP5 mRNA | CTD | PMID:17109745 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of DUSP5 mRNA | CTD | PMID:20488242 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of DUSP5 mRNA | CTD | PMID:16483693 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1622924 | 6480464 | Benzo(a)pyrene results in decreased expression of DUSP5 mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | increases expression | ISO | RGD:1345576 | 6480464 | Benzo(a)pyrene results in increased expression of DUSP5 mRNA | CTD | PMID:21632981 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:1345576 | 6480464 | Benzo(a)pyrene results in increased expression of DUSP5 mRNA | CTD | PMID:21871943 PMID:22316170 |
| benzo[a]pyrene | increases expression | ISO | RGD:1345576 | 6480464 | Benzo(a)pyrene results in increased expression of DUSP5 mRNA | CTD | PMID:21871943 |
| beta-D-glucosamine | multiple interactions | EXP | | 6480464 | Glucosamine inhibits the reaction [IL1B results in increased expression of DUSP5 mRNA] | CTD | PMID:17109745 |
| beta-D-glucosamine | increases expression | EXP | | 6480464 | Glucosamine results in increased expression of DUSP5 mRNA | CTD | PMID:17109745 |
| bilirubin | increases expression | ISO | RGD:1345576 | 6480464 | Bilirubin results in increased expression of DUSP5 mRNA | CTD | PMID:20196124 |
| bisphenol A | affects expression | ISO | RGD:1345576 | 6480464 | bisphenol A affects the expression of DUSP5 mRNA | CTD | PMID:20170705 |
| cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of DUSP5 mRNA | CTD | PMID:19010381 PMID:21297351 |
| calcitriol | multiple interactions | ISO | RGD:1345576 | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of DUSP5 mRNA | CTD | PMID:21592394 |
| calcitriol | increases expression | ISO | RGD:1345576 | 6480464 | Calcitriol results in increased expression of DUSP5 mRNA | CTD | PMID:21592394 PMID:16002434 |
| calcitriol | increases expression | ISO | RGD:1345576 | 6480464 | Calcitriol results in increased expression of DUSP5 mRNA | CTD | PMID:16002434 PMID:21592394 |
| cobalt dichloride | increases expression | ISO | RGD:1345576 | 6480464 | cobaltous chloride results in increased expression of DUSP5 mRNA | CTD | PMID:19320972 |
| copper atom | multiple interactions | ISO | RGD:1345576 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of DUSP5 mRNA | CTD | PMID:20971185 |
| copper(0) | multiple interactions | ISO | RGD:1345576 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of DUSP5 mRNA | CTD | PMID:20971185 |
| copper(2+) sulfate | increases expression | ISO | RGD:1345576 | 6480464 | Copper Sulfate results in increased expression of DUSP5 mRNA | CTD | PMID:19549813 |
| crocidolite asbestos | increases expression | ISO | RGD:1345576 | 6480464 | Asbestos, Crocidolite results in increased expression of DUSP5 mRNA | CTD | PMID:18687144 |
| curcumin | increases expression | ISO | RGD:1345576 | 6480464 | Curcumin results in increased expression of DUSP5 mRNA | CTD | PMID:17198877 |
| cyclosporin A | increases expression | ISO | RGD:1345576 | 6480464 | Cyclosporine results in increased expression of DUSP5 mRNA | CTD | PMID:20106945 |
| cyclosporin A | increases expression | ISO | RGD:1345576 | 6480464 | Cyclosporine results in increased expression of DUSP5 mRNA | CTD | PMID:20106945 PMID:21632981 |
| diarsenic trioxide | decreases expression | ISO | RGD:1345576 | 6480464 | arsenic trioxide results in decreased expression of DUSP5 mRNA | CTD | PMID:20016248 |
| dibutyl phthalate | increases expression | ISO | RGD:1622924 | 6480464 | Dibutyl Phthalate results in increased expression of DUSP5 mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of DUSP5 mRNA | CTD | PMID:21266533 |
| dioxygen | multiple interactions | ISO | RGD:1345576 | 6480464 | alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin co-treated with Oxygen deficiency] results in decreased expression of DUSP5 mRNA]; more ... | CTD | PMID:19578757 |
| diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of DUSP5 mRNA | CTD | PMID:21551480 |
| genistein | decreases expression | ISO | RGD:1345576 | 6480464 | Genistein results in decreased expression of DUSP5 mRNA | CTD | PMID:20884965 |
| hydrogen peroxide | increases expression | ISO | RGD:1345576 | 6480464 | Hydrogen Peroxide results in increased expression of DUSP5 | CTD | PMID:18687144 |
| mono(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of DUSP5 mRNA | CTD | PMID:16809437 |
| N-methyl-N-nitrosurea | increases expression | EXP | | 6480464 | Methylnitrosourea results in increased expression of DUSP5 mRNA | CTD | PMID:17412507 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:1345576 | 6480464 | Diethylnitrosamine results in increased expression of DUSP5 mRNA | CTD | PMID:21527772 |
| nickel sulfate | increases expression | ISO | RGD:1345576 | 6480464 | nickel sulfate results in increased expression of DUSP5 mRNA | CTD | PMID:16780908 |
| nicotinic acid | increases expression | EXP | | 6480464 | Niacin results in increased expression of DUSP5 mRNA | CTD | PMID:20303128 |
| ozone | increases expression | EXP | | 6480464 | Ozone results in increased expression of DUSP5 mRNA | CTD | PMID:16716893 |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of DUSP5 mRNA | CTD | PMID:17202762 |
| perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of DUSP5 mRNA | CTD | PMID:19162173 |
| phenobarbital | affects expression | ISO | RGD:1345576 | 6480464 | Phenobarbital affects the expression of DUSP5 mRNA | CTD | PMID:19159669 |
| pirinixic acid | multiple interactions | ISO | RGD:1345576 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of DUSP5 mRNA | CTD | PMID:19710929 |
| pirinixic acid | multiple interactions | ISO | RGD:1622924 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of DUSP5 mRNA | CTD | PMID:19710929 |
| progesterone | increases expression | ISO | RGD:1345576 | 6480464 | Progesterone results in increased expression of DUSP5 mRNA | CTD | PMID:18037150 |
| quercetin | increases expression | ISO | RGD:1345576 | 6480464 | Quercetin results in increased expression of DUSP5 mRNA | CTD | PMID:21632981 |
| raloxifene | multiple interactions | ISO | RGD:1345576 | 6480464 | [Raloxifene co-treated with ESR2 protein] results in increased expression of DUSP5 mRNA | CTD | PMID:19059307 |
| scopolamine | decreases expression | EXP | | 6480464 | Scopolamine Hydrobromide results in decreased expression of DUSP5 mRNA | CTD | PMID:17540011 |
| tamoxifen | increases expression | ISO | RGD:1345576 | 6480464 | Tamoxifen results in increased expression of DUSP5 mRNA | CTD | PMID:15604281 |
| tamoxifen | multiple interactions | ISO | RGD:1345576 | 6480464 | [Tamoxifen co-treated with ESR2 protein] results in increased expression of DUSP5 mRNA | CTD | PMID:19059307 |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:1345576 | 6480464 | tert-Butylhydroperoxide results in increased expression of DUSP5 mRNA | CTD | PMID:15336504 |
| testosterone | multiple interactions | ISO | RGD:1345576 | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of DUSP5 mRNA | CTD | PMID:21592394 |
| testosterone | increases expression | ISO | RGD:1345576 | 6480464 | Testosterone results in increased expression of DUSP5 mRNA | CTD | PMID:21592394 |
| valsartan | multiple interactions | ISO | RGD:1345576 | 6480464 | valsartan inhibits the reaction [AGT protein results in increased expression of DUSP5 mRNA] | CTD | PMID:19225232 |
| vanadyl sulfate | increases expression | ISO | RGD:1345576 | 6480464 | vanadyl sulfate results in increased expression of DUSP5 mRNA | CTD | PMID:16330358 |
| zinc atom | decreases expression | EXP | | 6480464 | Zinc results in decreased expression of DUSP5 mRNA | CTD | PMID:17074742 |
| zinc atom | increases expression | ISO | RGD:1345576 | 6480464 | Zinc deficiency results in increased expression of DUSP5 mRNA | CTD | PMID:22171008 |
| zinc atom | multiple interactions | ISO | RGD:1345576 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of DUSP5 mRNA | CTD | PMID:18593933 |
| zinc sulfate | decreases expression | EXP | | 6480464 | Zinc Sulfate results in decreased expression of DUSP5 mRNA | CTD | PMID:17074742 |
| zinc(0) | decreases expression | EXP | | 6480464 | Zinc results in decreased expression of DUSP5 mRNA | CTD | PMID:17074742 |
| zinc(0) | multiple interactions | ISO | RGD:1345576 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of DUSP5 mRNA | CTD | PMID:18593933 |
| zinc(0) | increases expression | ISO | RGD:1345576 | 6480464 | Zinc deficiency results in increased expression of DUSP5 mRNA | CTD | PMID:22171008 |